Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Efficacy of a new once-daily long-acting inhaled 2-agonist indacaterol versus twice-daily formoterol in COPD
2010
273 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
34.87
Efficacy of a new once-daily long-acting inhaled 2-agonist indacaterol versus twice-daily formoterol in COPD | Researchclopedia
·
Novartis (United Kingdom)
Roger Owen
·
Novartis (United Kingdom)
Mark Higgins
·
Novartis (United Kingdom)
Benjamin Krämer
·
Novartis (United States)
on behalf of the INVOLVE (INdacaterol: Value in COPD: Longer Term Validation of Efficacy and Safety) Study Investigators